4//SEC Filing
Mehra Uneek 4
Accession 0000950170-23-070016
CIK 0001650648other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:05 PM ET
Size
5.8 KB
Accession
0000950170-23-070016
Insider Transaction Report
Form 4
Mehra Uneek
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2023-12-11+75,000→ 75,000 totalExercise: $14.42Exp: 2033-12-10→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of December 11, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.
Documents
Issuer
4D Molecular Therapeutics, Inc.
CIK 0001650648
Entity typeother
Related Parties
1- filerCIK 0001881504
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 4:05 PM ET
- Size
- 5.8 KB